The Business Research Company’s Community Oncology Services Global Market Report 2021: COVID-19 Growth And Change To 2030
LONDON, GREATER LONDON, UK, April 6, 2021 /EINPresswire.com/ — Our reports have been revised for market size, forecasts, and strategies to take on 2021 after the COVID-19 impact: https://www.thebusinessresearchcompany.com/global-market-reports
Major companies are undergoing various acquisition and research collaboration in the community oncology services market to expand their services and offerings, which is gaining significant popularity over the recent years. According to a report published by Community Oncology Alliance in April 2020, the rate of community oncology practices acquired by hospitals increased by 9.7% during 2018 and 2020. For instance, in August 2020, The Community Cancer Center, a US-based clinic engaged in providing community-based cancer care, was acquired by Carle Health. Carle Health is a US-based hospital and healthcare company with more than 9,500 employees in its five hospitals and associated healthcare business. In addition to this, in May 2019, Amgen Inc., a US-based biopharmaceutical company, announced new research collaborations with community oncology networks. Amgen also launched Amgen Community Oncology Research Collaborators (ACORC), a new initiative to improve access to innovative oncology clinical research for community centers.
Other trends in the oncology industry include collaborations between companies. In May 2019, Amgen announced its decision to collaborate with community oncology service providers such as US Oncology Research and TRIO-US to enhance access by community centers to innovative oncology clinical research. This collaboration is expected to allow Amgen to significantly expand its clinical research footprint to more than 200 patient care sites across the U.S. and help community centers reach more than 900,000 new patients each year with investigational medicines.
Major players in the community oncology services industry are Community Care Physicians P.C., Nebraska Cancer Specialists, US Oncology, Inc. (McKesson Corporation), Tufts Medical Center., Doctors Medical Center, Oncology Specialists, S.C., and Baptist Cancer Center.
Read More On The Global Community Oncology Services Market Report:
The global community oncology services market is expected to decline from $70.98 billion in 2020 to $70.78 billion in 2021 at a compound annual growth rate (CAGR) of -0.3%. The slow decline in the cancer drugs market is attributed to COVID-19 restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The community oncology services market is expected to reach $69.97 billion in 2025 at a CAGR of -0.2%.
The global oncology market covered in this report is segmented by type into small community oncology clinics, medium community oncology clinics, large community oncology clinics, by cancer type into breast cancer, lung cancer, kidney cancer, liver cancer, ovarian cancer, prostate cancer, skin cancer, pancreatic cancer, blood cancer, colorectal cancer, others, and by therapy type into medical oncology, radiation oncology, surgical oncology, others.
Community Oncology Services Global Market Report 2021: COVID-19 Growth And Change To 2030 is one of a series of new reports from The Business Research Company that provides community oncology services market overview, forecast community oncology services market size and growth for the whole market, community oncology services market segments, and geographies, community oncology services market trends, community oncology services market drivers, restraints, leading competitors’ revenues, profiles, and market shares.
Request For A Sample Of The Global Community Oncology Services Market Report:
Here Is A List Of Similar Reports By The Business Research Company:
Community And Individual Services Global Market Report 2021: COVID-19 Impact and Recovery to 2030
Cancer Vaccines Global Market Report 2021: COVID-19 Growth And Change To 2030
Immuno-Oncology Drugs Global Market Report 2021: COVID-19 Growth And Change To 2030
Oncology Drugs Market – By Type (Blood Cancer, Breast Cancer, Lung Cancer, Prostate cancer, Colorectal Cancer, Cervical cancer, Kidney cancer, Gastric Cancer, Brain Tumor, Skin Cancer, Ovarian Cancer, Bladder Cancer, Pancreatic Cancer, Thyroid cancer, Others), By Drug Class Type (Targeted Therapy, Immunotherapy (Biologic Therapy), Chemotherapy, Hormonal Therapy), By Distribution Channel (Retail Pharmacies/Drug Stores, Hospital Pharmacies, Others), By Route Of Administration (Oral, Parenteral, Others), By Drug Classification (Branded, Generic), And By Region, Opportunities And Strategies – Global Forecast To 2030
Oncology Biosimilars Global Market Report 2021: COVID-19 Growth And Change To 2030
Oncology Devices Global Market Report 2021: COVID-19 Growth And Change to 2030
CAR-T Therapy Market – By Target Antigen (CD19 Therapy, CD22 Therapy, BCMA Therapy, Others), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Others), And By Region, Opportunities And Strategies – Global Forecast To 2030
Interested to know more about The Business Research Company?
Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx
The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology. TBRC excels in company, market, and consumer research.
Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293